Difference between revisions of "DZI20-210-Case-5"
From MGH Learn Pathology
(Created page with "{{dziCase |order_date=October 21, 2020 02:36:54 PM |user=Vn048 |dziorder=DZI20-210 |case_id=5 |publish_timestamp=Choose_date 13:00 |clinical_hx=86 yo man with tumor with ulcer...") |
(Added status template) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | {{ | + | {{ServiceRequestCase |
| − | | | + | |identifier=DZI20-210-Case-5 |
| − | | | + | |intent=order |
| − | | | + | |category=409073007 |
| − | | | + | |priority=routine |
| − | | | + | |orderDetail=case |
| − | | | + | |locationCode=learn |
| − | | | + | |basedOn=DZI20-210 |
| + | |code=faculty | ||
| + | |supportingInfo=Skin, right flank tumor: CD8+ tumor stage T-cell lymphoma. | ||
IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-. | IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-. | ||
| + | |reasonCode=86 yo man with tumor with ulceration for 3 months. (Guitart et al, Mod Path 30:761-72, 2017 , case #20) | ||
| + | |subject=MGH | ||
| + | |performer=VN048 | ||
| + | |authoredOn=October 21, 2020 02:36:54 PM | ||
| + | |requester=Vn048 | ||
| + | |sequence=5 | ||
| + | |access=public | ||
}} | }} | ||
| − | {{ | + | {{Media |
| − | | | + | |basedOn=DZI20-210-Case-5 |
| − | | | + | |type=image |
| − | | | + | |view=show |
| − | | | + | |partOf=DZI20-210 |
| − | | | + | |frames=1 |
| + | |reasonCode=H&E | ||
| + | |identifier=DZI20-210-Case-5_1 | ||
| + | |createdDateTime=October 21, 2020 02:36:54 PM | ||
| + | |operator=Vn048 | ||
| + | |subject=Z0FBQUFBQmZrRWh6QlpYdGtnNGg1QUVfdXlEckV2UlVCZW9WMjJEY3RBSi0xd1ZzM2FGaDdaN203RFZzVDlpaWpEcE5CUkw3bGY0MEFwZ2hXS3l4Y0VtVTQ4U0Z6bXZLSnc9PQ | ||
| + | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Vn048 | ||
| + | |authoredOn=October 21, 2020 02:36:54 PM | ||
}} | }} | ||
Latest revision as of 14:01, December 9, 2024